WGS

GeneDx Holdings Corp. $71.02 as of 2026-10-29
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.6%
Next 1 week
+1.0%
Next 1 month
+4.3%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 92
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.67%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.57 +4.5% · Seasonal tilt (5y) -0.2%
$53M/day volume 88% volatility -48% 1-year
52-week range · 28% of the way up · -58% from the high
$32.21$170.87

Earnings Full history →

Next report 2026-11-09 (Monday, after close, in 10 days) · EPS est. 0.07.

1-day std dev
29.0%
Finished up
55%
Biggest pop
+55.2%
Biggest drop
-49.2%

Standard deviation of the close-to-close move over the last 20 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-03 beat -0.19 0.01 +105.3% +12.0% +4.5% +20.5%
2026-05-04 miss -0.02 -0.28 -1407.8% -45.6% -49.2% -41.9%
2026-02-23 beat 0.12 0.14 +16.7% -2.0% +6.1% -9.6%
2025-10-28 beat 0.42 0.49 +15.9% -1.6% +5.2% +6.8%
2025-07-29 beat 0.11 0.50 +371.7% +24.0% +8.1% +25.6%
2025-04-30 beat 0.09 0.27 +215.2% -29.9% -42.8% -51.0%
2025-02-18 beat 0.10 0.64 +514.9% +24.4% +47.7% +25.5%
2024-10-29 beat -0.21 0.04 +120.2% +18.8% +49.9% +33.5%
2024-07-30 beat -0.30 -0.10 +65.7% +16.2% +8.6% -3.4%
2024-04-29 beat -0.67 -0.33 +51.1% +29.8% +55.2% +75.4%
2024-02-20 beat -0.65 -0.63 +2.9% -5.7% +32.6% +47.9%
2023-10-30 beat -1.31 -0.82 +37.4% -18.0% -30.3% -41.2%
2023-08-08 miss -1.31 -1.77 -34.8% -2.1% -12.6% -24.8%
2023-05-09 miss -1.48 -2.90 -96.2% -1.2% -2.4% -25.9%
2023-03-14 miss -5.28 -5.69 -7.8% +6.6% +1.4% +9.7%
2022-11-14 miss -5.28 -6.65 -26.0% -6.9% -12.2% -38.2%
2022-08-15 miss -5.61 -7.12 -27.0% -26.7% -33.3% -53.3%
2022-05-12 beat -9.24 -8.84 +4.3% +10.5% +19.2% +12.2%
2022-03-14 miss -7.26 -10.86 -49.5% +2.6% -0.4% +11.7%
2021-11-15 miss -5.28 -16.06 -204.2% -0.9% -6.8% -17.3%

Not investment advice.